TickerFacts.

Compare

iRhythm Holdings, Inc. vs Inspire Medical Systems, Inc. vs Tandem Diabetes Care Inc vs Mimedx Group, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yeariRhythm Holdings, Inc.
IRTC		Inspire Medical Systems, Inc.
INSP		Tandem Diabetes Care Inc
TNDM		Mimedx Group, Inc.
MDXG
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenue$747.14M$911.98M$1.01B$418.63M
Revenue growth (YoY)+26.2%+13.6%+7.9%+20.0%
Gross margin70.6%85.4%53.8%82.6%
Operating margin-7.7%5.6%-18.5%15.3%
Net margin-6.0%15.9%-20.2%11.6%
Net income-$44.55M$145.42M-$204.71M$48.58M
EPS (Diluted)-$1.39$4.89-$3.04$0.32
Operating cash flow$80.86M$116.98M-$9.72M$74.00M
Free cash flow$34.52M$78.48M-$29.67Mn/a
Cash & equivalents$236.01M$104.81M$90.63M$166.12M
Total assets$1.02B$907.32M$881.11M$342.65M
Total liabilities$867.30M$126.16M$725.94M$86.11M
Shareholders' equity$152.75M$781.16M$155.17M$256.55M
Return on year-end equity-29.2%18.6%-131.9%18.9%
Shares outstanding32.30M28.58M68.29M148.09M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yeariRhythm Holdings, Inc.Inspire Medical Systems, Inc.Tandem Diabetes Care IncMimedx Group, Inc.
Latest$747.14M
Ended 2025-12-31		$911.98M
Ended 2025-12-31		$1.01B
Ended 2025-12-31		$418.63M
Ended 2025-12-31
1 year earlier$591.84M
Ended 2024-12-31		$802.80M
Ended 2024-12-31		$940.20M
Ended 2024-12-31		$348.88M
Ended 2024-12-31
2 years earlier$492.68M
Ended 2023-12-31		$624.80M
Ended 2023-12-31		$747.72M
Ended 2023-12-31		$321.48M
Ended 2023-12-31
3 years earlier$410.92M
Ended 2022-12-31		$407.86M
Ended 2022-12-31		$801.22M
Ended 2022-12-31		$267.84M
Ended 2022-12-31
4 years earlier$322.82M
Ended 2021-12-31		$233.39M
Ended 2021-12-31		$702.80M
Ended 2021-12-31		$242.02M
Ended 2021-12-31